Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection
Abstract Objective: Compare outcomes of patients receiving high-dose oral beta-lactam versus standard oral therapy for Enterobacterales bacteremia from a urinary tract infection (UTI). Design: Retrospective, multicenter, observational cohort. Setting: Three Michigan community teaching hospital...
Main Authors: | Abigail C. Geyer, Kali M. VanLangen, Andrew P. Jameson, Lisa E. Dumkow |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X23004357/type/journal_article |
Similar Items
-
Short‐ and Long‐Term Cure Rates of Short‐Duration Trimethoprim‐Sulfamethoxazole Treatment in Female Dogs with Uncomplicated Bacterial Cystitis
by: S. Clare, et al.
Published: (2014-05-01) -
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
by: Ching-Lung Lo, et al.
Published: (2017-06-01) -
Beta-Lactam vs. Fluoroquinolone Monotherapy for <i>Pseudomonas aeruginosa</i> Infection: A Systematic Review and Meta-Analysis
by: Eric Reid, et al.
Published: (2021-12-01) -
Intravenous versus Oral Step-Down for the Treatment of <i>Staphylococcus aureus</i> Bacteremia in a Pediatric Population
by: Sarah Grace Gunter, et al.
Published: (2022-01-01) -
Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone
by: Chan, Jaclyn Chi Lin, et al.
Published: (2021)